REVIEW OF CLINICALLY IMPORTANT DRUG-INTERACTIONS WITH LITHIUM

Citation
Ns. Harvey et S. Merriman, REVIEW OF CLINICALLY IMPORTANT DRUG-INTERACTIONS WITH LITHIUM, Drug safety, 10(6), 1994, pp. 455-463
Citations number
NO
Categorie Soggetti
Toxicology,"Pharmacology & Pharmacy","Public, Environmental & Occupation Heath
Journal title
ISSN journal
01145916
Volume
10
Issue
6
Year of publication
1994
Pages
455 - 463
Database
ISI
SICI code
0114-5916(1994)10:6<455:ROCIDW>2.0.ZU;2-U
Abstract
The therapeutic dosage of lithium is close to the toxic level, and dru gs reducing the renal clearance of lithium can produce the most seriou s adverse effects. When used in combination with psychiatric drugs aff ecting mood, the therapeutic potential of lithium may be enhanced, and earlier concern regarding possible neurotoxic interactions with neuro leptics appear poorly substantiated. A number of specific interactions of low incidence have also been reported which should be borne in min d when new medications are introduced. The ready availability of lithi um concentration monitoring in body fluids makes it possible to alter the effects of some potentially interactive drugs that may still need to be given in combination with lithium.